Matches in Wikidata for { <http://www.wikidata.org/entity/Q94408948> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q94408948 description "article scientifique publié en 2017" @default.
- Q94408948 description "wetenschappelijk artikel" @default.
- Q94408948 description "наукова стаття" @default.
- Q94408948 name "ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA" @default.
- Q94408948 name "ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA" @default.
- Q94408948 type Item @default.
- Q94408948 label "ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA" @default.
- Q94408948 label "ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA" @default.
- Q94408948 prefLabel "ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA" @default.
- Q94408948 prefLabel "ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA" @default.
- Q94408948 P1433 Q94408948-49EAC08C-1FC7-4B1D-9A5F-1281B149C6F3 @default.
- Q94408948 P1476 Q94408948-B956BC85-1E90-4F37-8269-306618FA9967 @default.
- Q94408948 P2093 Q94408948-10A4D54B-6AE9-460F-9871-3294AFCEBF4A @default.
- Q94408948 P2093 Q94408948-1C7A23AB-CF11-4F09-BF68-F54F83667473 @default.
- Q94408948 P2093 Q94408948-3DB76BC3-8D9D-4BF1-AA89-1092F792D090 @default.
- Q94408948 P2093 Q94408948-3EC339D3-C795-4ED6-BABD-32B5D4C834C1 @default.
- Q94408948 P2093 Q94408948-7B9B3DB4-D45D-435D-AA36-C59147A7E2CB @default.
- Q94408948 P2093 Q94408948-84E786B3-9D69-4420-944F-D4C5EF2D625B @default.
- Q94408948 P2093 Q94408948-A045A238-46F6-41A0-830D-0443B166BEE6 @default.
- Q94408948 P2093 Q94408948-A3B7AF01-394C-4FB9-A8DD-5C8D2EB902F0 @default.
- Q94408948 P2093 Q94408948-A806A523-0D1B-4CAF-944D-A88DD0251ECA @default.
- Q94408948 P2093 Q94408948-B8491AF5-AD8D-4D3A-8B72-FC826A2BF33A @default.
- Q94408948 P2093 Q94408948-DE02EB4D-9BC7-443B-B138-4584A847C467 @default.
- Q94408948 P2093 Q94408948-E1F25047-0839-4E3B-A823-429ED01B73FA @default.
- Q94408948 P2093 Q94408948-E689FD69-5FA6-48E5-9548-2D44E171581B @default.
- Q94408948 P2093 Q94408948-EF8EC009-3314-47DE-9B5D-DB7ABB54F7F3 @default.
- Q94408948 P2093 Q94408948-FC0B64BC-FC66-4877-A745-5651DF9D7F11 @default.
- Q94408948 P304 Q94408948-54628EED-930F-48D1-8A72-9539489C76BB @default.
- Q94408948 P31 Q94408948-A1AA1C52-E3F0-4ADC-9BBD-B3CABF58768C @default.
- Q94408948 P356 Q94408948-F683C0DE-758C-4F02-9995-B48858EF20C8 @default.
- Q94408948 P433 Q94408948-C17A0E2D-29CB-4482-A464-F325B66858A6 @default.
- Q94408948 P478 Q94408948-FD37CC2D-4101-40EC-8C82-957BEA565B79 @default.
- Q94408948 P50 Q94408948-2C2820BE-4129-458F-A781-5331F3E69217 @default.
- Q94408948 P577 Q94408948-47A030C2-F2C9-44DC-BD38-C59EB1195BF4 @default.
- Q94408948 P921 Q94408948-5099F7C1-711D-4D41-AD4E-14B2D239B5CC @default.
- Q94408948 P921 Q94408948-5350CF21-7525-4F96-950B-935673A10F4A @default.
- Q94408948 P932 Q94408948-C4514F51-FFBB-4F18-9696-616C35C9C8C9 @default.
- Q94408948 P356 NOX168.065 @default.
- Q94408948 P1433 Q15724471 @default.
- Q94408948 P1476 "ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA" @default.
- Q94408948 P2093 "Anna Nowak" @default.
- Q94408948 P2093 "Antoine F Carpentier" @default.
- Q94408948 P2093 "Chiedzo Mpofu" @default.
- Q94408948 P2093 "Dana M Cernea" @default.
- Q94408948 P2093 "Francois Dubois" @default.
- Q94408948 P2093 "Frank Saran" @default.
- Q94408948 P2093 "Gaetano Finocchiaro" @default.
- Q94408948 P2093 "George Fountzilas" @default.
- Q94408948 P2093 "Hans-Joerg Urban" @default.
- Q94408948 P2093 "Josef Pichler" @default.
- Q94408948 P2093 "Martina Makrutzki" @default.
- Q94408948 P2093 "Miquel Gil Gil" @default.
- Q94408948 P2093 "Olivier Chinot" @default.
- Q94408948 P2093 "Vittorina Zagonel" @default.
- Q94408948 P2093 "Warren Mason" @default.
- Q94408948 P304 "vi17-vi18" @default.
- Q94408948 P31 Q13442814 @default.
- Q94408948 P356 "10.1093/NEUONC/NOX168.065" @default.
- Q94408948 P433 "Suppl 6" @default.
- Q94408948 P478 "19" @default.
- Q94408948 P50 Q51349290 @default.
- Q94408948 P577 "2017-11-06T00:00:00Z" @default.
- Q94408948 P921 Q282142 @default.
- Q94408948 P921 Q413299 @default.
- Q94408948 P932 "5693008" @default.